T425-1093 Screening compound: N-{2-[benzyl(ethyl)amino]ethyl}-8-phenylimidazo[1,2-a]pyrazine-2-carboxamide

T425-1093 Screening compound: N-{2-[benzyl(ethyl)amino]ethyl}-8-phenylimidazo[1,2-a]pyrazine-2-carboxamide
T425-1093 Screening compound: N-{2-[benzyl(ethyl)amino]ethyl}-8-phenylimidazo[1,2-a]pyrazine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T425-1093
N-{2-[benzyl(ethyl)amino]ethyl}-8-phenylimidazo[1,2-a]pyrazine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T425-1093

Molecular Formula

C24H25N5O (C24 H25 N5 O)

Compound Name

N-{2-[benzyl(ethyl)amino]ethyl}-8-phenylimidazo[1,2-a]pyrazine-2-carboxamide

IUPAC name

N-{2-[benzyl(ethyl)amino]ethyl}-8-phenylimidazo[12-a]pyrazine-2-carboxamide

SMILES

CCN(CCNC(c1cn(ccnc2-c3ccccc3)c2n1)=O)Cc1ccccc1

InChI

InChI=1S/C24H25N5O/c1-2-28(17-19-9-5-3-6-10-19)15-13-26-24(30)21-18-29-16-14-25-22(23(29)27-21)20-11-7-4-8-12-20/h3-12,14,16,18H,2,13,15,17H2,1H3,(H,26,30)

InChI Key

ILQVYZPOARULDK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29022803

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

399.5

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.206

Distribution Coefficient, logD

2.746

Water Solubility, LogSw

-3.06

Polar Surface Area

47.940

Acid Dissociation Constant (pKa)

13.07

Base Dissociation Constant (pKb)

7.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

T425-1093 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

CNS Targets (44014 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with T425-1093 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T425-1093?
Check Price and Availability of T425-1093, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T425-1093 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T425-1093
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T425-1093
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T425-1093 available by request